CRBP
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ · USHealthcareBiotechnology
$8.89-1.33%
Price as of Jul 20, 2026
CRBP growth
Corbus Pharmaceuticals Holdings, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- -67.4%
- EBIT
- -52.6%
- EPS
- +3.9%
- Free cash flow
- -46.6%
- Operating cash flow
- -46.6%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- +17.3%
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- -75.1%
- Net income
- -95.3%
- EPS
- -60.3%
- Free cash flow
- -54.3%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.